There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on TechTarget (TTGT – Research Report) and Braze (BRZE – Research Report) with bullish sentiments.
TechTarget (TTGT)
In a report released today, Joshua Reilly from Needham maintained a Buy rating on TechTarget, with a price target of $90.00. The company’s shares closed last Friday at $65.66, close to its 52-week low of $56.83.
According to TipRanks.com, Reilly is ranked 0 out of 5 stars with an average return of
TechTarget has an analyst consensus of Strong Buy, with a price target consensus of $84.00.
See today’s best-performing stocks on TipRanks >>
Braze (BRZE)
In a report released today, Scott Berg from Needham maintained a Buy rating on Braze, with a price target of $70.00. The company’s shares closed last Friday at $43.34.
According to TipRanks.com, Berg is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Braze with a $48.82 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on TTGT:
- Kroger (KR), Costco (COST): Grocery Store Stocks to Combat Rising Food Prices
- PureGold Announces Record Gold Production in August; Reaffirms Q3 2022 Guidance
- Integra Announces 11,000 m Drill Program on 60 Million Tonnes of Low-Grade Gold-Silver Mineralized Stockpiles From Previous Operators, Potential to Increase Mine Life and Expand Production
- Entera Bio Presents Dose Proportional Absorption and Correlation to BMD Clinical Response Data from its Phase 2 Study of EB613 in Post-Menopausal Osteoporosis Patients at the ASBMR 2022 Annual Meeting
- Analysts Offer Insights on Healthcare Companies: Spectrum Pharmaceuticals (SPPI), MoonLake Immunotherapeutics (MLTX) and Cabaletta Bio (CABA)
